Vickie Reed
Directeur/Membre du Conseil chez EVOKE PHARMA, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Vickie Reed
Sociétés | Poste | Début | Fin |
---|---|---|---|
EVOKE PHARMA, INC. | Directeur/Membre du Conseil | 13/05/2021 | - |
Independent Dir/Board Member | 13/05/2021 | - | |
DMK PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 24/05/2022 | - |
Independent Dir/Board Member | 24/05/2022 | - |
Historique de carrière de Vickie Reed
Anciens postes connus de Vickie Reed
Sociétés | Poste | Début | Fin |
---|---|---|---|
MIRATI THERAPEUTICS | Comptroller/Controller/Auditor | 06/01/2020 | 16/05/2022 |
Directeur Financier/CFO | 01/11/2021 | 16/05/2022 | |
Corporate Officer/Principal | 01/12/2016 | 06/01/2020 | |
ZOGENIX, INC. | Comptroller/Controller/Auditor | - | 01/01/2022 |
Directeur Financier/CFO | - | 01/01/2022 | |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Vickie Reed
The University of Colorado | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
EVOKE PHARMA, INC. | Health Technology |
DMK PHARMACEUTICALS CORPORATION | Health Technology |
Entreprise privées | 3 |
---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Vickie Reed
- Expérience